Adeno-Associated Virus 2-Mediated Hepatocellular Carcinoma is Very Rare in Korean Patients
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The incidence and etiology of hepatocellular carcinoma (HCC) vary widely according to race and geographic regions. The insertional mutagenesis of adeno-associated virus 2 (AAV2) has recently been considered a new viral etiology of HCC. The aim of this study was to investigate the frequency and clinical characteristics of AAV2 in Korean patients with HCC. Methods: A total of 289 unrelated Korean patients with HCC, including 159 Hepatitis-B-related cases, 16 Hepatitis-C-related cases, and 114 viral serology-negative cases, who underwent surgery at the Samsung Medical Center in Korea from 2009 to 2014 were enrolled in this study. The presence of AAV2 in fresh-frozen tumor tissues was investigated by DNA PCR and Sanger sequencing. The clinical and pathological characteristics of AAV2-associated HCC in these patients were compared with previous findings in French patients. Results: The AAV2 detection rate in Korean patients (2/289) was very low compared with that in French patients (11/193). Similar to the French patients, the Korean patients with AAV2-related HCC showed no signs of liver cirrhosis. The Korean patients were younger than the French patients with the same AAV2-associated HCC; the ages at diagnosis of the two Korean patients were 47 and 39 yr, while the median age of the 11 French patients was 55 yr (range 43-90 yr). Conclusions: AAV2-associated HCC was very rare in Korean patients with HCC. Despite a limited number of cases, this study is the first to report the clinical characteristics of Korean patients with AAV2-associated HCC. These findings suggest epidemiologic differences in viral hepatocarcinogenesis between Korean and European patients.
Abstract
Background: The incidence and etiology of hepatocellular carcinoma (HCC) vary widely according to race and geographic regions. The insertional mutagenesis of adeno-associated virus 2 (AAV2) has recently been considered a new viral etiology of HCC. The aim of this study was to investigate the frequency and clinical characteristics of AAV2 in Korean patients with HCC. Methods: A total of 289 unrelated Korean patients with HCC, including 159 Hepatitis-B-related cases, 16 Hepatitis-C-related cases, and 114 viral serology-negative cases, who underwent surgery at the Samsung Medical Center in Korea from 2009 to 2014 were enrolled in this study. The presence of AAV2 in fresh-frozen tumor tissues was investigated by DNA PCR and Sanger sequencing. The clinical and pathological characteristics of AAV2-associated HCC in these patients were compared with previous findings in French patients. Results: The AAV2 detection rate in Korean patients (2/289) was very low compared with that in French patients (11/193). Similar to the French patients, the Korean patients with AAV2-related HCC showed no signs of liver cirrhosis. The Korean patients were younger than the French patients with the same AAV2-associated HCC; the ages at diagnosis of the two Korean patients were 47 and 39 yr, while the median age of the 11 French patients was 55 yr (range 43-90 yr). Conclusions: AAV2-associated HCC was very rare in Korean patients with HCC. Despite a limited number of cases, this study is the first to report the clinical characteristics of Korean patients with AAV2-associated HCC. These findings suggest epidemiologic differences in viral hepatocarcinogenesis between Korean and European patients.
참고문헌 (14)
- El-Serag HB, "Epidemiology of viral hepatitis and hepatocellular carcinoma", Gastroenterology, 142, pp.1264~1273 (2012)
- de Martel C, "World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma", Hepatology, 62, pp.1190~1200 (2015)
- Nault JC, "Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas", Nat Genet, 47, pp.1187~1193 (2015)
- Alam S, "Adeno-associated virus type 2 induces apoptosis in human papillomavirus-infected cell lines but not in normal keratinocytes", J Virol, 83, pp.10286~10292 (2009)
- Bantel-Schaal U, "Integration of adeno-associated virus 2 DNA in human MKR melanoma cells induces a peptide with oncosuppressive properties", Int J Cancer, 92, pp.537~544 (2001)
- Alam S, "Adeno-associated virus type 2 infection of nude mouse human breast cancer xenograft induces necrotic death and inhibits tumor growth", Cancer Biol Ther, 15, pp.1013~1028 (2014)
- Donsante A, "AAV vector integration sites in mouse hepatocellular carcinoma", Science, 317, pp.477~ (2007)
- Bell P, "Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver", Mol Ther, 14, pp.34~44 (2006)
- Calcedo R, "Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses", J Infect Dis, 199, pp.381~390 (2009)
- Chen Y, "VirusSeq:software to identify viruses and their integration sites using next-generation sequencing of human cancer tissue", Bioinformatics, 29, pp.266~267 (2013)
- Lee WP, "MOSAIK: a hash-based algorithm for accurate next-generation sequencing short-read mapping", PLoS One, 9, pp.e90581~ (2014)
- Laredj LN, "Adeno-associated virus activates an innate immune response in normal human cells but not in osteosarcoma cells", J Virol, 85, pp.13133~13143 (2011)
- Nault JC, "Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas", Nat Genet, 47, pp.1187~1193 (2015)
- Russell DW, "Adeno-associated virus finds its disease", Nat Genet, 47, pp.1104~1105 (2015)